On October 29, 2024, Soleil Boughton, Chief Legal Officer of Hims & Hers Health Inc (HIMS, Financial), executed a sale of 2,339 shares of the company. The transaction was filed on the same day with the SEC. Following this transaction, the insider now owns 169,935 shares of Hims & Hers Health Inc.
Hims & Hers Health Inc, a telehealth company, provides a modern approach to health and wellness. The company's platform connects consumers with licensed healthcare professionals, enabling them to access high-quality care for numerous conditions from the comfort and privacy of their home.
The shares were sold at a price of $23.16, valuing the transaction at approximately $54,172.24. This sale is part of a broader trend observed over the past year, where Hims & Hers Health Inc has seen a total of 90 insider sells and only 1 insider buy. Over the past year, Soleil Boughton has sold a total of 302,051 shares and has not purchased any shares.
The company's market cap stands at approximately $4.81 billion, with the stock price of $23.16 reflecting a price-earnings ratio of 278.00. This ratio is significantly higher than both the industry median of 18.15 and the company's historical median.
According to the GF Value, the intrinsic value of Hims & Hers Health Inc is estimated at $16.29 per share, making the current price-to-GF-Value ratio 1.42. This indicates that the stock is significantly overvalued.
The valuation metrics suggest caution, as the high price-earnings ratio and the price-to-GF-Value ratio both indicate that the stock may be overpriced relative to its intrinsic value. Investors might consider these factors and the recent insider selling activity when evaluating their investment in Hims & Hers Health Inc.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
